Literature DB >> 16943672

Crohn's disease activity index and Vienna classification--is it worthwhile to calculate before surgery?

M Rentsch1, A Beham, H J Schlitt, K W Jauch.   

Abstract

BACKGROUND: Crohn's disease (CD) patients with increased disease activity may reveal an increased risk for perioperative complications. The "Crohn's disease activity index" (CDAI) and the "Vienna classification" (VC) were developed for standardized disease activity estimations. The significance of these scores to predict extent, type and early outcome of surgery in CD patients was analyzed.
METHODS: In 179 surgically treated CD patients, the CDAI and VC were assessed from a prospective database. Relations of the scores with CD risk factors, type, number, location and complications of surgery were analyzed.
RESULTS: VC behavior and location subtypes were associated with distinct types of surgery (i.e. "strictureplasty" in "stricturing disease", "colon surgery" in "colon involvement"), but not with surgery type and extent or outcome. Surgery extent (i.e. with 5 vs. 3 "surgical sites" 425 +/- 25 vs. 223.3 +/- 25) and complications (357.1 +/- 36.9 (with) vs. 244.4 +/- 13 (without)) were associated with elevated CDAI levels; however, nicotine abuse remained the only significant risk factor for perioperative complications after multiple logistic regression.
CONCLUSION: The significance of VC or CDAI for predicting the extent of surgery or complications is limited. None of the tested variables except preoperative nicotine abuse influenced the likelihood for perioperative complications. Copyright (c) 2006 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2006        PMID: 16943672     DOI: 10.1159/000095397

Source DB:  PubMed          Journal:  Dig Surg        ISSN: 0253-4886            Impact factor:   2.588


  5 in total

Review 1.  Comparison of strictureplasty and endoscopic balloon dilatation for stricturing Crohn's disease--review of the literature.

Authors:  Andreas G Wibmer; Anton J Kroesen; Jörn Gröne; Heinz-Johannes Buhr; Joerg-Peter Ritz
Journal:  Int J Colorectal Dis       Date:  2010-07-14       Impact factor: 2.571

Review 2.  Midkine in inflammation.

Authors:  Ludwig T Weckbach; Takashi Muramatsu; Barbara Walzog
Journal:  ScientificWorldJournal       Date:  2011-12-27

3.  Reduced Transferrin Levels in Active Inflammatory Bowel Disease.

Authors:  Malgorzata Matusiewicz; Katarzyna Neubauer; Paulina Lewandowska; Andrzej Gamian; Malgorzata Krzystek-Korpacka
Journal:  Biomed Res Int       Date:  2017-10-31       Impact factor: 3.411

4.  Peripheral Lymphocytes of Patients with Inflammatory Bowel Disease Have Altered Concentrations of Key Apoptosis Players: Preliminary Results.

Authors:  Katarzyna Neubauer; Barbara Woźniak-Stolarska; Małgorzata Krzystek-Korpacka
Journal:  Biomed Res Int       Date:  2018-11-01       Impact factor: 3.411

5.  Matrix metalloproteinase-9: its interplay with angiogenic factors in inflammatory bowel diseases.

Authors:  Malgorzata Matusiewicz; Katarzyna Neubauer; Magdalena Mierzchala-Pasierb; Andrzej Gamian; Malgorzata Krzystek-Korpacka
Journal:  Dis Markers       Date:  2014-03-31       Impact factor: 3.434

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.